| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44641f38fea7e343f658a1db19058838 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
| filingDate |
2018-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f949d53d80a6e0697da9bee60db3ec4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_441dd0ba358bf85be317144e0e5ae2d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faffaa56695bb1a1ca95b672cd11a25f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_848f3a4632332dbf46585ab64f75bb85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4263996cdbd62d64829238635132e09 |
| publicationDate |
2019-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201922251-A |
| titleOfInvention |
Anticancer agent |
| abstract |
This article discloses a medical method for administering a compound that regulates C-C chemokine receptor type 4 (CCR4) for the treatment of Epstein Barr virus (EBV) -positive cancer and malignant diseases. |
| priorityDate |
2017-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |